This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.86% per year. These returns cover a period from January 1, 1988 through February 2, 2026. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View the Zacks #1 Rank List
stock-price-movement: Archive
EyePoint (EYPT) Surges 15.2%: Is This an Indication of Further Gains?
by Zacks Equity Research
EyePoint (EYPT) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
EYPTPositive Net Change TRDAPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Strength Seen in Ormat Technologies (ORA): Can Its 5.1% Jump Turn into More Strength?
by Zacks Equity Research
Ormat Technologies (ORA) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions could translate into further price increase in the near term.
ORAPositive Net Change OPTTNegative Net Change
momentum-stocks moving-average-crossover price-performance stock-price-movement stocks-moving-today
Strength Seen in Masimo (MASI): Can Its 34.2% Jump Turn into More Strength?
by Zacks Equity Research
Masimo (MASI) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
MASINegative Net Change UFPTNegative Net Change
momentum-stocks moving-average-crossover price-performance stock-price-movement stocks-moving-today
Global Business Travel Group, Inc. (GBTG) Soars 8.9%: Is Further Upside Left in the Stock?
by Zacks Equity Research
Global Business Travel Group, Inc. (GBTG) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
GBTGPositive Net Change BRZEPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
ZIM (ZIM) Surges 25.5%: Is This an Indication of Further Gains?
by Zacks Equity Research
ZIM (ZIM) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
ZIMPositive Net Change ESEAPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Immunocore (IMCR) Upgraded to Strong Buy: Here's Why
by Zacks Equity Research
Immunocore (IMCR) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
IMCRNegative Net Change
earnings-estimates earnings-estimates-revisions earnings-outlook rating-upgrade stock-price-movement zacks-consensus-estimate zacks-rank
What Makes Verastem (VSTM) a New Buy Stock
by Zacks Equity Research
Verastem (VSTM) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
VSTMNegative Net Change
earnings-estimates earnings-estimates-revisions earnings-outlook rating-upgrade stock-price-movement zacks-consensus-estimate zacks-rank
KB Financial (KB) Upgraded to Strong Buy: Here's What You Should Know
by Zacks Equity Research
KB Financial (KB) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
KBPositive Net Change
earnings-estimates earnings-estimates-revisions earnings-outlook rating-upgrade stock-price-movement zacks-consensus-estimate zacks-rank
ING (ING) Upgraded to Strong Buy: Here's What You Should Know
by Zacks Equity Research
ING (ING) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
INGPositive Net Change
earnings-estimates earnings-estimates-revisions earnings-outlook rating-upgrade stock-price-movement zacks-consensus-estimate zacks-rank
NetEase (NTES) Upgraded to Buy: Here's Why
by Zacks Equity Research
NetEase (NTES) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
NTESNegative Net Change
earnings-estimates earnings-estimates-revisions earnings-outlook rating-upgrade stock-price-movement zacks-consensus-estimate zacks-rank